10-15 Associates’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$15.8M Sell
70,055
-3,477
-5% -$796K 3.07% 4
2020
Q2
$15.8M Sell
73,532
-485
-0.7% -$91.7K 3.18% 6
2020
Q1
$12.1M Buy
74,017
+6,762
+10% +$1.3M 2.82% 11
2019
Q4
$14.2M Buy
67,255
+2,135
+3% +$416K 2.67% 9
2019
Q3
$12.5M Buy
65,120
+703
+1% +$136K 2.58% 11
2019
Q2
$11.9M Sell
64,417
-28
-0% -$5.03K 2.58% 14
2019
Q1
$11.3M Buy
64,445
+3,785
+6% +$595K 2.44% 17
2018
Q4
$8.55M Buy
+60,660
New +$9.6M 2.09% 24

Other funds holding ACN

10-15 Associates's ACN Position: Q3 2020 in Review

10-15 Associates reduced its Accenture (ACN) stake by 4.7% in Q3 2020, selling an estimated $796K and leaving 70,055 shares worth $15.8M. The position accounts for 3.07% of the portfolio, ranked #4.

10-15 Associates first reported a position in ACN in Q4 2018 and has held it in 8 quarters since. 1,636 funds tracked by Wall St. Rank hold ACN as of Q3 2020.

  • 10-15 Associates held 70,055 shares of Accenture worth $15.8M as of Q3 2020.
  • 10-15 Associates sold 3,477 Accenture shares in Q3 2020, an estimated $796K.
  • Accenture made up 3.07% of 10-15 Associates's portfolio in Q3 2020, its #4 holding.
  • 10-15 Associates first reported a position in Accenture in Q4 2018 and has held it in 8 quarters since.
  • 1,636 funds tracked by Wall St. Rank held Accenture as of Q3 2020.

Based on 10-15 Associates's 13F filing for Q3 2020, filed 13 Oct 2020.